MedTrace Logo

Software Refraction With Mobilerone Versus Retinoscopy

NCT06059521 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-09-28

No results posted yet for this study

Summary

Software refraction in the mobilerone for myopia and astigmatism is a novel medical device for myopia adults and elder children with or without astigmatism. And the investigators would like to test its accuracy and efficacy as well as safety.

Conditions

  • Myopia
  • Myopia, Moderate
  • Astigmatism

Interventions

DEVICE

Software refraction with Eye Test Technology in a mobilerone

Refraction is done by software App by a mobilerone software installed.

DEVICE

Retinoscopy

Retinoscopy is an objective refraction method with retinoscope.

Sponsors & Collaborators

  • University of Notre Dame Australia

    collaborator OTHER

  • Beijing Airdoc Technology Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
46 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-15
Primary Completion
2025-12-30
Completion
2030-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06059521 on ClinicalTrials.gov